MannKind reported $1.44B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Adma Biologics USD 4.08B 267M Sep/2025
Dynavax Technologies USD 1.19B 421M Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Insmed USD 19.09B 5.22B Jun/2025
MacroGenics USD 111M 34M Sep/2025
MannKind USD 1.14B 392M Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novo Nordisk USD 306.38B 3.87B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Xencor USD 559M 191M Jun/2025